Boehringer Ingelheim Animal Health, a leading global animal health company, participated in the 2018 international trade show ‘From Feed to Food for the Middle East and Africa’, which took place in Abu Dhabi, UAE recently.

Over 8000 visitors and 300 participants attended the second edition of the event to discuss the latest trends and findings around animal feed to food solutions and technological advancement within the industry.

The event brought together leading experts in animal health from the region to highlight the latest innovative as well as medical solutions for production animals.

Boehringer Ingelheim Animal Health held a session with a focus on avian and cattle, and the different preventive solutions the company provides. The avian and cattle segments continue to grow due to an increased demand, particularly in the Middle East and Africa region (MEA).

Enrique Manzoni, managing director of Boehringer Ingelheim Middle East, Turkey and Africa (META) said, “Animal Health is an important topic that directly links to our daily lives and nutrition. In large parts of the world, including our region, avian and cattle will remain the fastest growing source of animal protein. To that extent, preventive vaccination is one approach to controlling any diseases. We have applied a lot of advances in this area and our commitment is to support in the investment of a healthier animal ecosystem, which in return would reflect in healthier communities.”

“When animals are healthy, humans are healthy too. Boehringer Ingelheim works to provide sustainable animal health solutions including vaccines with proven effectiveness and safety that accommodates the region’s specific needs.

“As known leaders and innovators in this field, Boehringer Ingelheim is frequently consulted for assistance in identifying new diseases and formulating new therapies or new diagnostic techniques to control diseases. We will continue to seek methods to further research and develop ground-breaking solutions for the animal health industry in line with the company’s business objectives,’’ added Manzoni.

Boehringer Ingelheim works with advanced products, not only to reduce disease and encourage wellness in animals, but also to build the reputation and enhance the quality of care delivered by veterinarians.

Earlier last year, Boehringer Ingelheim finalized its swap transaction to acquire Merial, a business which was valued at €11.4 billion ($14.1 billion), following a positive year for the animal health business. The Boehringer Ingelheim animal health business is now the second largest company in the global animal health market, and is the top provider worldwide of parasiticides and vaccines for pets, companion animals and production animals. The combined company is now the global leader in the pets, equine and veterinary public health categories, with a strong position in avian and cattle. – TradeArabia News Service